Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06869057 · ClinicalTrials.gov registry record · NA
Re-Engineered Discharge for Diabetes Care Transitions
A NA study, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 412
- Enrollment target
NCT06869057 is a NA study that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 412 participants.
The verdict
NCT06869057, a NA study, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 412 participants
- Enrollment target
Study Summary
The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
Interventions
- OTHER Treatment as Usual (TAU)
- BEHAVIORAL REDDCAT2 Post-Discharge Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2026-06-08 |
| Est. Completion | 2029-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06869057
The ClinicalTrials.gov registry entry for NCT06869057 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT06869057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06869057 about?
NCT06869057 is a clinical study titled "Re-Engineered Discharge for Diabetes Care Transitions". The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
What is the current status of trial NCT06869057?
This trial is currently recruiting. It is a NA study. The enrollment target is 412 participants. The study started on 2026-06-08. Estimated completion is 2029-05-30.
What interventions are being tested in trial NCT06869057?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), REDDCAT2 Post-Discharge Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06869057?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.